The Role of Photodynamic Therapy in the Esophagus

Seth A. Gross, Herbert C. Wolfsen

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Photodynamic therapy (PDT) is a drug and device therapy using photosensitizer drugs activated by laser light for mucosal ablation. Porfimer sodium PDT has been used extensively with proven long-term efficacy and durability for the ablation of Barrett esophagus and high-grade dysplasia. and early esophageal adenocarcinoma. However, continued use is hampered by an associated stricture risk and prolonged photosensitivity (4-6 weeks). Promising single-center European studies using other forms of PDT, such as aminolevulinic acid PDT, have not been replicated elsewhere, limiting the widespread use of other forms of PDT. Future use of PDT in esophageal disease depends on the development of improved dosimetry and patient selection to optimize treatment outcomes, while minimizing adverse events and complications.

Original languageEnglish (US)
Pages (from-to)35-53
Number of pages19
JournalGastrointestinal Endoscopy Clinics of North America
Issue number1
StatePublished - Jan 2010


  • Aminolevulinic acid
  • HPPH (Photochlor)
  • Porfimer sodium
  • Subsquamous Barrett glands
  • mTHPC (Foscan)

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'The Role of Photodynamic Therapy in the Esophagus'. Together they form a unique fingerprint.

Cite this